Krebs von den Lungen ‐6 levels in untreated idiopathic pulmonary fibrosis

ConclusionsIt is identified that serum KL-6 is a useful noninvasive biomarker to help improve the certainty of IPF diagnosis from other interstitial lung disease and assist evaluation of disease severity and prognosis.

Source: The Clinical Respiratory Journal - January 26, 2022 Category: Respiratory Medicine Authors: Dingyuan Jiang, Huijuan Xiao, Run Dong, Jing Geng, Bingbing Xie, Yanhong Ren, Huaping Dai Tags: ORIGINAL ARTICLE Source Type: research